Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $144.4 million versus the consensus estimate of $144.01 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.